Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Homeobox protein Nkx-2.5 (NKX2-5) is a highly conserved transcription factor that plays a critical role in heart development and function. It belongs to the NK-2 class of homeodomain proteins and acts as a key component of the "cardiac kernel," a group of transcription factors essential for the specification, proliferation, and differentiation of cardiac precursor cells into mature cardiomyocytes. NKX2-5 initiates the cardiac gene program early in embryogenesis and regulates genes involved in cardiac morphogenesis, chamber formation, and the conduction system. Mutations in NKX2-5 are a common cause of inherited congenital heart disease, particularly atrial septal defects and conduction disorders. While essential for cardiac development, there are currently no drugs that directly target NKX2-5, as its modulation carries significant risks due to its central role in maintaining cardiac structure and function.
No direct drug mechanism known; gene mutations underpin disease rather than pharmacological modulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Homeobox protein Nkx-2.5 (NKX2-5).